Lexpos News

National Patient Safety Alert: Shortage of methylphenidate prolonged-release capsules and tablets, lisdexamfetamine capsules, and guanfacine prolonged-release tablets. National Patient Safety Alert Reference Number: NatPSA/2023/011/DHSC Date issued: 27th September 2023 Brief description of the problem There are supply disruptions affecting various strengths of the following medications which are licensed for the treatment of attention deficit hyperactivity [...]

The post National Patient Safety Alert: Shortage of methylphenidate prolonged-release capsules and tablets, lisdexamfetamine capsules, and guanfacine prolonged-release tablets. appeared first on Community Pharmacy England.

The October 2023 Drug Tariff has been updated to include a deadline for submission of any outstanding referred back prescriptions to the NHS Business Services Authority (NHSBSA) for payment. All prescriptions that have been referred-back must be completed and returned to the NHSBSA no later than 18 months from the date they are first sent [...]

The post Deadline for submission of outstanding referred back prescriptions appeared first on Community Pharmacy England.

The Drug Tariff Preface published monthly lists additions, deletions and other changes to products listed in the Drug Tariff. Below is a summary of the changes coming into effect from 1 October 2023. Key g Special container – This product is a special container and should be dispensed in its complete original pack size. n Item [...]

The post Drug Tariff Watch – October 2023 appeared first on Community Pharmacy England.

A disallowed item is one that has NOT been passed for payment by the NHS Business Services Authority (NHSBSA). Please check your disallowed items history on Manage Your Service (MYS) portal to identify the list of unpaid items and reasons why the item was disallowed by the NHSBSA. If you believe an item has been [...]

The post Check and challenge your disallowed items using MYS appeared first on Community Pharmacy England.

A new Medicines and Healthcare products Regulatory Agency (MHRA) Drug Safety Update (Vol 17 Issue 2 September 2023) has been published and includes articles on: Statins: very infrequent reports of myasthenia gravis Fluoroquinolone antibiotics: suicidal thoughts and behaviour Letters and medicine recalls sent to healthcare professionals in August 2023. To see the latest MHRA Drug [...]

The post MHRA Drug Safety Update: September 2023 appeared first on Community Pharmacy England.